FindTrial
Sign In

A Clinical trial to study the clinical and haematological inflammatory parameters in patients treated with oral squamous cell carcinoma

Evaluation of Clinical and Haematological Inflammatory profile in patients treated for oral squamous cell carcinoma- A Prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042224
Enrollment
49
Registered
2022-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K137- Other and unspecified lesions of oral mucosa

Interventions

None listed

Sponsors

Saveetha dental college
Lead Sponsor
Arvind M
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients histologically diagnosed with oral squamous cell carcinoma. 2)Patients with untreated oral squamous cell carcinoma scheduled for surgery/radiotherapy/chemotherapy

Exclusion criteria

Exclusion criteria: 1)Patients with treated oral squamous cell carcinoma 2)Patients with factors that could influence Neutrophil-Lymphocyte ratio,Lymphocyte-Monocyte ratio,Platelet-Lymphocyte ratio such as infections,chronic inflammatory diseases,chronic hematologic diseases and recent treatments with steroids

Design outcomes

Primary

MeasureTime frame
To assess the biochemical values of Neutrophil-Lymphocyte ratio,Lymphocyte-Monocyte ratio,Platelet-Lymphocyte ratio with standard values in patients with OSCC and evaluate prognosis.Timepoint: one year—

Secondary

MeasureTime frame
To assess the biochemical values of Neutrophil-Lymphocyte ratio,Lymphocyte-Monocyte ratio,Platelet-Lymphocyte ratio with standard values in patients with OSCC at regular intervals of 2 months for 1 year and evaluate prognosis.Timepoint: pre op and post op at second,fourth,sixth,eighth,tenth and twelth month—

Countries

India

Contacts

Public ContactDr Arvind M

Saveetha dental College

arvindmuthukrishnan@yahoo.com9444303303

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026